These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 1676969)
1. In vivo and in vitro studies into the immunological changes following iodine 131 therapy for Graves' disease. Wilson R; McKillop JH; Jenkins C; Thomson JA Eur J Nucl Med; 1991; 18(4):265-8. PubMed ID: 1676969 [TBL] [Abstract][Full Text] [Related]
2. The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease: prevalence, mechanism and prognosis. Aizawa Y; Yoshida K; Kaise N; Fukazawa H; Kiso Y; Sayama N; Hori H; Abe K Clin Endocrinol (Oxf); 1997 Jan; 46(1):1-5. PubMed ID: 9059550 [TBL] [Abstract][Full Text] [Related]
3. Changes in the properties of the thyrotropin receptor antibody in patients with Graves' disease after radioiodine treatment. Cho BY; Shong YK; Chung JK; Lee MC; Lee HK; Koh CS; Min HK Thyroidology; 1989 Dec; 1(3):109-14. PubMed ID: 2484872 [TBL] [Abstract][Full Text] [Related]
4. Pattern of recovery of the hypothalamic-pituitary-thyroid axis following radioactive iodine therapy in patients with Graves' disease. Uy HL; Reasner CA; Samuels MH Am J Med; 1995 Aug; 99(2):173-9. PubMed ID: 7625422 [TBL] [Abstract][Full Text] [Related]
5. Changes in thyroid volume in response to radioactive iodine for Graves' hyperthyroidism correlated with activity of thyroid-stimulating antibody and treatment outcome. Murakami Y; Takamatsu J; Sakane S; Kuma K; Ohsawa N J Clin Endocrinol Metab; 1996 Sep; 81(9):3257-60. PubMed ID: 8784079 [TBL] [Abstract][Full Text] [Related]
6. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease]. Chen W; Man N; Li YS; Shan ZY; Teng WP Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113 [TBL] [Abstract][Full Text] [Related]
7. Antithyroid drugs inhibit radioiodine-induced increases in thyroid autoantibodies in hyperthyroid Graves' disease. Nakazato N; Yoshida K; Mori K; Kiso Y; Sayama N; Tani JI; Nakagawa Y; Ito S Thyroid; 1999 Aug; 9(8):775-9. PubMed ID: 10482369 [TBL] [Abstract][Full Text] [Related]
8. Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage. Chiovato L; Fiore E; Vitti P; Rocchi R; Rago T; Dokic D; Latrofa F; Mammoli C; Lippi F; Ceccarelli C; Pinchera A J Clin Endocrinol Metab; 1998 Jan; 83(1):40-6. PubMed ID: 9435414 [TBL] [Abstract][Full Text] [Related]
9. Characterization of thyroid-stimulating blocking antibodies that appeared during transient hypothyroidism after radioactive iodine therapy. Kung AW; Lau KS; Kohn LD Thyroid; 2000 Oct; 10(10):909-17. PubMed ID: 11081257 [TBL] [Abstract][Full Text] [Related]
10. Long-term effect of radioiodine therapy on the thyroid antibodies in the patients of Graves' disease with postirradiation hypothyroidism. Chang TC; Chang CC; Chen FW; Liaw KY Taiwan Yi Xue Hui Za Zhi; 1986 Dec; 85(12):1177-82. PubMed ID: 2880926 [No Abstract] [Full Text] [Related]
11. Role of thyroid-stimulating blocking antibody in patients who developed hypothyroidism within one year after 131I treatment for Graves' disease. Yoshida K; Aizawa Y; Kaise N; Fukazawa H; Kiso Y; Sayama N; Hori H; Nakazato N; Tani J; Abe K Clin Endocrinol (Oxf); 1998 Jan; 48(1):17-22. PubMed ID: 9509063 [TBL] [Abstract][Full Text] [Related]
12. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies. Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965 [TBL] [Abstract][Full Text] [Related]
13. Specific effects of radioiodine treatment on TSAb and TBAb levels in patients with Graves' disease. Michelangeli VP; Poon C; Topliss DJ; Colman PG Thyroid; 1995 Jun; 5(3):171-6. PubMed ID: 7580264 [TBL] [Abstract][Full Text] [Related]
15. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles. Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951 [TBL] [Abstract][Full Text] [Related]
16. Changes in the properties of the thyrotropin receptor antibody in patients with Graves' disease after radioiodine treatment. Cho BY; Shong YK; Chung JK; Lee MC; Lee HK; Koh CS; Min HK Korean J Intern Med; 1990 Jan; 5(1):51-7. PubMed ID: 1980206 [TBL] [Abstract][Full Text] [Related]
17. The effect of pre-operative potassium iodide therapy on antibody production. Wilson R; McKillop JH; Thomson JA Acta Endocrinol (Copenh); 1990 Nov; 123(5):531-4. PubMed ID: 1979466 [TBL] [Abstract][Full Text] [Related]